Editas Medicine Inc (NASDAQ:EDIT)

Delayed Data
As of Mar 05
 +1.14 / +2.82%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 42.50, with a high estimate of 81.00 and a low estimate of 14.00. The median estimate represents a +2.41% increase from the last price of 41.50.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Editas Medicine Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.70%
Growthannually -69.49%


Growthquarterly -44.17%
Growthannually -72.52%
Key to the earnings and sales forecast charts.